Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2

Jia Wang(University of Alabama at Birmingham), Ichiro Nakano(University of Alabama at Birmingham)
Journal of Clinical Investigation
July 23, 2017
Cited by 101


Related Papers